HCW Biologics (NASDAQ:HCWB)has been cleared by the U.S. FDA to proceed to evaluate its lead drug candidate, HCW9218, in a first-in-human Phase 1b clinical trial in patients with advanced pancreatic ...
网页链接HCW Biologics (NASDAQ:HCWB)has been cleared by the U.S. FDA to proceed to evaluate its lead drug candidate, HCW9218, in a first-in-human Phase 1b clinical trial in patients with advanced pancreatic ...
网页链接
精彩评论